Riggs Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-39
| Closed | -$20.5K | – | 688 |
|
|
2025
Q2 | $20.5K | Sell |
39
-7
| -15% | -$3.91K | 0.01% | 242 |
|
|
2025
Q1 | $29.2K | Buy |
46
+1
| +2% | +$688 | 0.01% | 194 |
|
|
2024
Q4 | $31.6K | Sell |
45
-10
| -18% | -$8.39K | 0.01% | 179 |
|
|
2024
Q3 | $57.8K | Hold |
55
| – | – | 0.02% | 143 |
|
|
2024
Q2 | $57.8K | Hold |
55
| – | – | 0.02% | 134 |
|
|
2024
Q1 | $52.9K | Hold |
55
| – | – | 0.02% | 132 |
|
|
2023
Q4 | $48.3K | Sell |
55
-10
| -15% | -$8.23K | 0.02% | 138 |
|
|
2023
Q3 | $53.5K | Hold |
65
| – | – | 0.02% | 135 |
|
|
2023
Q2 | $46.7K | Hold |
65
| – | – | 0.02% | 144 |
|
|
2023
Q1 | $53.4K | Hold |
65
| – | – | 0.02% | 135 |
|
|
2022
Q4 | $46.9K | Sell |
65
-50
| -43% | -$36.9K | 0.02% | 137 |
|
|
2022
Q3 | $79K | Buy |
115
+15
| +15% | +$9.44K | 0.03% | 118 |
|
|
2022
Q2 | $59K | Hold |
100
| – | – | 0.02% | 124 |
|
|
2022
Q1 | $70K | Hold |
100
| – | – | 0.02% | 139 |
|
|
2021
Q4 | $63K | Hold |
100
| – | – | 0.02% | 154 |
|
|
2021
Q3 | $61K | Hold |
100
| – | – | 0.02% | 139 |
|
|
2021
Q2 | $56K | Hold |
100
| – | – | 0.02% | 150 |
|
|
2021
Q1 | $47K | Hold |
100
| – | – | 0.01% | 148 |
|
|
2020
Q4 | $48K | Buy |
+100
| New | +$54K | 0.01% | 133 |
|
|
2020
Q3 | – | Sell |
-100
| Closed | -$62K | – | 238 |
|
|
2020
Q2 | $62K | Hold |
100
| – | – | 0.03% | 95 |
|
|
2020
Q1 | $48K | Hold |
100
| – | – | 0.03% | 102 |
|
|
2019
Q4 | $38K | Hold |
100
| – | – | 0.02% | 137 |
|
|
2019
Q3 | $27K | Sell |
100
-50
| -33% | -$14.8K | 0.01% | 146 |
|
|
2019
Q2 | $47K | Hold |
150
| – | – | 0.03% | 122 |
|
|
2019
Q1 | $61K | Hold |
150
| – | – | 0.04% | 101 |
|
|
2018
Q4 | $56K | Hold |
150
| – | – | 0.04% | 95 |
|
|
2018
Q3 | $60K | Hold |
150
| – | – | 0.03% | 97 |
|
|
2018
Q2 | $52K | Hold |
150
| – | – | 0.02% | 110 |
|
|
2018
Q1 | $52K | Hold |
150
| – | – | 0.02% | 115 |
|
|
2017
Q4 | $56K | Hold |
150
| – | – | 0.02% | 114 |
|
|
2017
Q3 | $67K | Hold |
150
| – | – | 0.03% | 105 |
|
|
2017
Q2 | $74K | Hold |
150
| – | – | 0.03% | 103 |
|
|
2017
Q1 | $58K | Hold |
150
| – | – | 0.03% | 107 |
|
|
2016
Q4 | $55K | Hold |
150
| – | – | 0.03% | 113 |
|
|
2016
Q3 | $60K | Hold |
150
| – | – | 0.03% | 108 |
|
|
2016
Q2 | $52K | Hold |
150
| – | – | 0.03% | 113 |
|
|
2016
Q1 | $54K | Hold |
150
| – | – | 0.04% | 91 |
|
|
2015
Q4 | $81K | Hold |
150
| – | – | 0.04% | 87 |
|
|
2015
Q3 | $70K | Hold |
150
| – | – | 0.04% | 83 |
|
|
2015
Q2 | $77K | Hold |
150
| – | – | 0.04% | 92 |
|
|
2015
Q1 | $68K | Hold |
150
| – | – | 0.03% | 93 |
|
|
2014
Q4 | $62K | Hold |
150
| – | – | 0.03% | 97 |
|
|
2014
Q3 | $54K | Buy |
+150
| New | +$50.3K | 0.03% | 95 |
|
Other funds holding REGN
Riggs Asset Management's REGN Position: Q3 2025 in Review
Riggs Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 39 shares — an estimated $20.5K sold.
Riggs Asset Management first reported a position in REGN in Q3 2014 and held it in 43 quarters. The position peaked at $81K in Q4 2015. 1,245 funds tracked by Wall St. Rank hold REGN as of Q3 2025.
- Riggs Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 39 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $20.5K.
- Riggs Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 43 quarters.
- Riggs Asset Management's Regeneron Pharmaceuticals position peaked at $81K in Q4 2015.
- 1,245 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.